<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04343482</url>
  </required_header>
  <id_info>
    <org_study_id>STU00205895</org_study_id>
    <nct_id>NCT04343482</nct_id>
  </id_info>
  <brief_title>Maternal Non-Stress Testing</brief_title>
  <official_title>Wireless Wearable Maternal Fetal Sensors for Non-Stress Testing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Percent agreement of vital signs monitoring between the experimental sensor and standard of&#xD;
      care monitoring&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Anticipated">February 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Device comparison to standard monitoring</measure>
    <time_frame>3 years</time_frame>
    <description>The primary outcome measure is concordance of FHR tracing assessments from Rogers sensor recordings with those obtained from the current standard of care electronic fetal monitoring systems.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Qualitative analyses of sensor output</measure>
    <time_frame>3 years</time_frame>
    <description>Qualitative analyses of FHR, MHR, BP, pulse oximetry, and UC data capture from the sensors will be performed for the purpose of optimizing signal-to-noise filtering of raw data collected during the study. Any adverse events will be recorded such as skin irritation (expected to be negligible).</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pregnant Women</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>wearable vital signs sensor</intervention_name>
    <description>vital signs monitoring during maternal non-stress testing</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Maternal age &gt;18 years old&#xD;
&#xD;
          -  Pregnant mothers &gt;26 weeks undergoing nonstress testing or delivering&#xD;
&#xD;
          -  Singleton pregnancy&#xD;
&#xD;
          -  No fetal abnormality or chromosomal abnormality&#xD;
&#xD;
          -  Subjects willing and able to comply with requirements of the protocol&#xD;
&#xD;
          -  Nurses and clinicians who will be administering the non-stress test to the pregnant&#xD;
             subject&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women who refuse to signed the informed consent form&#xD;
&#xD;
          -  Maternal age under 18 years old&#xD;
&#xD;
          -  Multiple pregnancy&#xD;
&#xD;
          -  Known major fetal malformation or chromosomal abnormality&#xD;
&#xD;
          -  Medical or obstetric problem that would preclude the use of abdominal electrodes&#xD;
&#xD;
          -  Inability to consent to this study due to medical illness, diminished intellectual&#xD;
             capacity, or language barrier&#xD;
&#xD;
          -  Women using pacemakers&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Northwestern Medicine Prentice Women's Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>March 30, 2020</study_first_submitted>
  <study_first_submitted_qc>April 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2020</study_first_posted>
  <last_update_submitted>May 6, 2021</last_update_submitted>
  <last_update_submitted_qc>May 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Shuai (Steve) Xu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

